BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Komeda Y, Sakurai T, Sakai K, Morita Y, Hashimoto A, Nagai T, Hagiwara S, Matsumura I, Nishio K, Kudo M. Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: A case report. World J Clin Cases 2020; 8(24): 6389-6395 [PMID: 33392322 DOI: 10.12998/wjcc.v8.i24.6389]
URL: https://www.wjgnet.com/2307-8960/full/v8/i24/6389.htm
Number Citing Articles
1
S. V. Semochkin, T. A. Mitina, T. N. Tolstykh. Management of immune thrombocytopenia during COVID-19 pandemicRussian journal of hematology and transfusiology 2021; 66(1): 20 doi: 10.35754/0234-5730-2021-66-1-20-36
2
Yuanzhuo Wang, Ziqi Wan, Rui Jin, Tianming Xu, Yan Ouyang, Baihui Wang, Gechong Ruan, Xiaoyin Bai. Tofacitinib for extraintestinal manifestations of inflammatory bowel disease: A literature reviewInternational Immunopharmacology 2022; 105: 108517 doi: 10.1016/j.intimp.2022.108517
3
Yuanming Yang, Yiwei Hua, Huan Zheng, Rui Jia, Zhining Ye, Guifang Su, Yueming Gu, Kai Zhan, Kairui Tang, Shuhao Qi, Haomeng Wu, Shumin Qin, Shaogang Huang. Biomarkers prediction and immune landscape in ulcerative colitis: Findings based on bioinformatics and machine learningComputers in Biology and Medicine 2024; 168: 107778 doi: 10.1016/j.compbiomed.2023.107778
4
Ahmed Hussein Subki, Manal Ismail Bokhary, Sultan Abdulrahman Alandijani, Mohannad Abdulrahman Aljehani, Ahmed Wasel Alharbi, May Alzahrani, Saud Suliman Almuhammadi, Bassim Tahseen Albeirouti, Mohamed Abdulmajid Abduljabar, Silvio Danese. Resolved Hypereosinophilic Syndrome and Immune Thrombocytopenic Purpura in Ulcerative Colitis Patients Post Colectomy: A Case Series and Literature ReviewJournal of Inflammation Research 2022; : 6373 doi: 10.2147/JIR.S365094
5
Joseph Sleiman, Rhonda M. Brand, Reetesh Pai, Randall E. Brand, John Rhee, Marc Schwartz, Diwakar Davar. Mirroring UC care pathways in refractory immune checkpoint inhibitor (ICI)-mediated colitis: distinct features and common pathwaysClinical Journal of Gastroenterology 2023; 16(5): 680 doi: 10.1007/s12328-023-01826-6